Nerudia have today announced that Dr Paul Marshall has joined the team as Regulatory Principal, to support customers with Medicinal, PMTA and TPD projects. As a former Senior Pharmaceutical Assessor for nicotine and CNS related products at the UK MHRA (Medicines and Healthcare products Regulatory Agency), he brings invaluable experience to the role and will report to Rob Burton, Nerudia Head of Consultancy and Compliance.
nerudia-press-release (PDF)
